Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.19.3.a.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash $ 13,185 $ 89
Prepaid expenses 9,400 12,991
Total current assets 22,585 13,080
Total Assets 22,585 13,080
Current liabilities    
Accounts payable 189,022 191,714
Accrued expenses 419,607 421,000
Accrued interest payable 630,271 537,118
Related party payables 897,447 1,423,984
Derivative liabilities 52,700
Stock subscriptions payable 2,574 1,271
Notes payable - current - related parties * Includes unamortized debt discount related to detached warrants of $26,506 and $8,074 at September 30, 2019 and December 31, 2018, respectively 673,036 697,770
Notes payable - current - non-related parties * Includes unamortized debt discount related to convertible notes of none and $5,920 at September 30, 2019 and December 31, 2018, respectively 229,574 163,654
Total current liabilities 3,094,231 3,436,511
Total Liabilities 3,094,231 3,436,511
Stockholders' Deficit    
Preferred stock, $0.00001 par value; 22,000,000 shares authorized, no shares issued or outstanding as of September 30, 2019 and December 31, 2018
Common stock, $0.00001 par value; 800,000,000 shares authorized; 214,626,540 and 116,751,078 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 2,146 1,172
Additional paid-in capital 15,750,746 14,887,804
Accumulated deficit (18,771,905) (18,262,136)
Total Transbiotec, Inc. stockholders' deficit (3,019,013) (3,373,146)
Noncontrolling interest (52,633) (50,285)
Total Stockholders' Deficit (3,071,646) (3,423,431)
Total Liabilities and Stockholders' Deficit 22,585 13,080
Series A Convertible Preferred stock [Member]    
Stockholders' Deficit    
Preferred stock, $0.00001 par value; 22,000,000 shares authorized, no shares issued or outstanding as of September 30, 2019 and December 31, 2018 $ 14
Series A-1 Convertible Preferred stock [Member]    
Stockholders' Deficit    
Series A-1 Convertible Preferred stock, $0.00001 par value; 1,000,000 shares authorized, no shares issued and outstanding as of September 30, 2019 and December 31, 2018